Sodium Loxoprofen eye drops (Lewwin Pharmaceutical /Aobo Pharmaceutical)
洛索洛芬钠滴眼液（莱恩医药/奥博医药）
Report date: 2025/07/30 20:01:17
Base Information
Drug NameSodium Loxoprofen eye drops (Lewwin Pharmaceutical /Aobo Pharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesGuangdong Lewwin Pharmaceutical Research Institute Co LtdGuangzhou Aobo Pharmaceutical Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesGuangzhou Aobo Pharmaceutical Technology Co LtdGuangdong Lewwin Pharmaceutical Research Institute Co Ltd
Inactive CompaniesN/A
Active Indications +[4]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A